This educational series, which includes 2 audiocasts, presents practical considerations for using novel treatments for patients with Classical Hodgkin lymphoma. The first audiocast focuses on individualizing treatment, and the second explores best practices for managing treatment-related adverse events.
"Best Practices for Implementing Cancer Immunotherapy in the Community” is a new ACCC education opportunity that offers two ACCC-member programs customized learning for their multidisciplinary teams delivering immunotherapy for cancer, including an on-site training.
The Association of Community Cancer Centers (ACCC) has joined with the Oncology Nursing Society (ONS) and The France Foundation to support a series of live Grand Rounds/Tumor Boards, “PARP Inhibitors: Advancing Personalized Medicine for Metastatic Breast Cancer Patients.”
ACCC member cancer programs are invited to participate in a live Grand Rounds program where a subject matter expert will travel to participating institutions to lead a one-hour accredited session. The Grand Rounds will provide the multidisciplinary cancer team with strategies to appropriately incorporate genetic testing and poly (ADP-ribose) polymerase (PARP) inhibitor therapy for patients with metastatic breast cancer (MBC).